Robitussin recalled nationwide for microbial contamination
As of now, no symptoms or illnesses have been reported from this recall
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Robitussin has been recalled nationwide for contamination.
According to the US Food and Drug Administration, Haleon, the British multinational conglomerate, announced on 24 January that it would be recalling “eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult” because of “microbial contamination”.
“In immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection,” the US Food and Drug Administration stated in its release.
Non-immunocompromised individuals are less likely to experience life-threatening illnesses or infections. However, the agency noted that “the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out”.
Robitussin temporarily relieves cold or flu symptoms, respiratory allergies, and hay fever.
The customers who’ve purchased this product are urged to stop using it immediately. Haleon has already began contacting its distributors and customers to provide detailed instructions on how to return the rest of their supply.
“Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product,” the FDA advised.
At this time, Haleon hasn’t reported any symptoms experienced by consumers from this recall.
Still, if one does exhibit any reactions or issues, the FDA is encouraging them to log it with their MedWatch Adverse Event Reporting program. This can be done either online, through regular mail via a form, or by fax (to 1-800-FDA-0178).
The Independent has contacted Haleon for a comment.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments